Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Insulet Stock: Analyst Estimates & Ratings

With a market cap of $22.8 billion, Insulet Corporation (PODD) is a prominent medical device company specializing in innovative insulin delivery solutions, best known for its flagship Omnipod® Insulin Management System. Headquartered in Acton, Massachusetts, Insulet has carved out a strong niche in the global diabetes care market by offering a tubeless, wearable insulin pump designed to simplify diabetes management and improve quality of life for patients.

Shares of PODD have significantly outpaced the broader market over the past 52 weeks. PODD stock has soared 77.8% over this period, while the broader S&P 500 Index ($SPX) has gained 14.3%. Moreover, shares of PODD are up 26% on a YTD basis, compared to SPX’s 9.5% rise.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.